Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on November 7, 2007
Chest, doi:10.1378/chest.07-1710
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.07-1710v1
133/4/845    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Licker, M.
Right arrow Articles by Ellenberger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Licker, M.
Right arrow Articles by Ellenberger, C.
Related Content
Right arrowRelated Editorial

Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection

Marc Licker, MD*; Jean-Marie Tschopp, MD#; John Robert, MD{dagger}; Jean-Georges Frey, MD#; John Diaper, RN* and Christoph Ellenberger, MD*

*Department of Anesthesiology, University Hospital, CH-1211 Geneva, Switzerland {dagger}Thoracic Surgery, University Hospital, CH-1211 Geneva, Switzerland #Internal Medicine, University Hospital, CH-1211 Geneva, Switzerland

Abstract

BackgroundIschemia-reperfusion injuries, fluid overload and cardiac insufficiency may all contribute to alveolar and interstitial lung edema. We hypothesized that aerosolized salbutamol would reduce extravascular lung water and improve oxygenation after lung resection, by stimulating epithelial fluid clearance and cardiovascular function.

DesignBlinded, randomized, cross-over trial.

MethodsWe selected 24 patients with risk factors for lung edema. Aerosolized drugs (salbutamol 5 mg vs. ipratropium 0.5 mg) were given on 2 consecutive trials, with a 6-hours washout period, on the day of surgery (POD 0) as well as on the first postoperative day (POD1). Before and 50 min after the end of drug administration, we determined the oxygenation index (PaO2/FIO2 ratio), the extravascular lung water index (EVLWI), the pulmonary vascular permeability index (PVPI) and the cardiac index (CI) using the single indicator thermal dilution technique.

ResultsComplete data were obtained in 21 patients. On POD0, the EVLWI was increased compared with preoperative values (13.0±3.8 vs. 9.1±4.4, P<0.001); salbutamol treatment induced significant increases in PaO2/FIO2 ratio (+25±13%) that was associated with decreases in EVLWI (-18±10%, P<0.05) and in PVPI (-19±10%, P<0.05) along with increased cardiac index (+23±11 %, P<0.05).

On POD1, repeated nebulization of salbutamol induced significant increases in PaO2/FIO2 ratio and CI (+22±10% and 19±11%, respectively) whereas both EVLWI and PVPI remained unchanged.

Nebulization of ipratropium bromide did not produce significant hemodynamic and respiratory changes on POD0 and POD1.

ConclusionsAerosolized salbutamol accelerates the resolution of lung edema, improves blood oxygenation and stimulated cardiovascular function after lung resection in high-risk patients.

Key Words: Acute lung injury • thoracic surgery • beta-adrenergic receptor • salbutamol


Related Editorial

Aerosolized β-Adrenergic Agonist Therapy Reduces Pulmonary Edema Following Lung Surgery
Michael A. Matthay and Carolyn S. Calfee
Chest 2008 133: 833-835. [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American College of Chest Physicians.